Do not blame the private doctors for dengue!

Image via malaysiakini.com
From Malaysia Kini - The Federation of Private Medical Practitioners’ Associations, Malaysia (FPMPAM) would like to issue the following comments in response to the comments from the Malaysian heath minister on Jan 28, 2015 that private doctors fail to detect symptoms of dengue early.

Our members in general practitioner (GP) and family clinics have noted increasing number of dengue cases presenting with differing clinical patterns since the year 2000. Our doctors have been on unrelenting high alert for dengue cases since the year 2000.

It should be clearly stated that existing commercially available test kits cannot confirm the diagnosis of dengue in the early stages of the disease. What is most important is a high index of suspicion for all cases and the proper use of the test at the appropriate time.

This decision is best left to the attending doctor, to advise on adequate fluid consumption, monitor the patient regularly for danger signs and to refer problematic cases with potential complications to hospitals for further management. This has been the standard operating procedure recommended by the Health Ministry.

It is thus not correct that private primary care doctors cannot diagnose dengue in more than 99 percent of cases as was reported.

The alternative is to direct private doctors to send all cases of clinically suspected dengue i.e., virtually all cases with febrile illness to the public hospitals for further screening and management. This will mean crippling the already overloaded hospital facilities.

The majority of dengue cases do not need hospital care. We would like to emphasise that our private GPs are adequately trained and equipped to diagnose and manage such cases of dengue and should be appreciated for their effort to manage this disease at the primary care level.

Comments

Popular posts from this blog

Semaglutide vs Tirzepatide Muscle Loss: Which Preserves More Lean Mass?

GLP-1 Hub 2026: Approved Drugs, Pills vs Injections, Retatrutide & Safety

How to Prevent Muscle Loss on GLP-1 Drugs: Protein, Resistance Training & Body Composition Guide (2026)

GLP-1 Cost and Coverage 2026: Self-Pay, Insurance and Pill Prices

GLP-1 Manual 2026: The Complete Guide to GLP-1 Drugs, Benefits, Risks, Dosing, Muscle Loss & Long-Term Strategy

Telehealth Peptide Providers 2026: How to Compare Prescription GLP-1s, Other Peptides, Compounding, Clinical Oversight and Pharmacy Sources

Semaglutide vs Tirzepatide vs Orforglipron: Which GLP-1 Drug Is Best for Weight Loss and Diabetes in 2026?

Ozempic vs Wegovy vs Mounjaro vs Zepbound: Differences, Evidence, Safety and Access (2026)

Ozempic Face: Causes, Evidence, Prevention, Fillers, Biostimulators and Skin Tightening (2026)

Peptide Therapy in 2026: What the Evidence Says About BPC-157, TB-500, MOTS-c and More